Company

Celldex Therapeutics, Inc. (CLDX)

Standardized SEC financial data for Celldex Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000744218 · NASDAQ · In Vitro & In Vivo Diagnostic Substances.

Gross margin

87.1%

Operating margin

-1000.0%

Net margin

-1000.0%

Revenue growth (YoY)

-78.0%

Return on equity

-49.1%

Free cash flow

-$213.7M

Current ratio

10.48×

EPS (diluted)

$-3.90

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$7.4M	$4.7M	$2.4M	$6.9M	$7.0M	$1.5M
Cost of revenue	$200K	$100K	$100K	$300K	$200K	$200K
Gross profit	$7.2M	$4.6M	$2.3M	$6.6M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$43.8M	$39.1M	$29.4M	$34.8M	$28.4M	$28.9M
Total current assets	$197.8M	$410.8M	$317.7M	$431.7M	$747.2M	$534.7M
Property, plant & equipment	$3.8M	$3.6M	$3.7M	$4.1M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$40.4M	-$60.9M	-$103.7M	-$107.3M	-$157.8M	-$210.9M
Capital expenditures	$1.6M	$1.2M	$1.8M	$1.8M	$1.9M	$2.7M
Free cash flow	-$42.0M	-$62.2M	-$105.6M	-$109.1M

Get CLDX data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CLDX/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CLDX/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View CLDX filings on SEC EDGAR →